Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Emgality
Emgality
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
Sat, 05/4/19 - 04:54 pm
migraines
CGRP blockers
Aimovig
Amgen
Ajovy
Teva Pharmaceutical
Emgality
Eli Lilly
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
migraines
Alder Biopharmaceuticals
Teva
Eli Lilly
Amgen
Emgality
Ajovy
eptinezumab
Lilly claims fast FDA review for Emgality in cluster headache
Pharmaforum
Tue, 03/5/19 - 11:55 am
Eli Lilly
migraines
CGRP blockers
Emgality
episodic cluster headache
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
Reuters
Sat, 01/26/19 - 11:56 am
CVS Health
migraines
Amgen
Teva Pharmaceutical
Eli Lilly
Aimovig
Ajovy
Emgality
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Don't fret about Lilly's 3rd-to-market start in CGRP, exec says. It's got big plans in migraine and pain, too
Fierce Pharma
Wed, 01/9/19 - 09:38 am
Eli Lilly
Emgality
migraines
CGRP blockers
Lilly's third-to-market Emgality nets FDA 'breakthrough' in cluster headache
Fierce Pharma
Thu, 11/15/18 - 11:37 pm
Eli Lilly
Emgality
cluster headaches
FDA
breakthrough therapies
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Wed, 10/17/18 - 09:22 am
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Fierce Pharma
Thu, 09/27/18 - 11:25 pm
Eli Lilly
Emgality
migraines
Pages
« first
‹ previous
1
2